158 related articles for article (PubMed ID: 23183001)
1. Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase.
Kocić J; Santibañez JF; Krstić A; Mojsilović S; Ilić V; Bugarski D
Int J Biochem Cell Biol; 2013 Feb; 45(2):464-75. PubMed ID: 23183001
[TBL] [Abstract][Full Text] [Related]
2. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
3. BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation.
Santibanez JF; Obradović H; Krstić J
Acta Histochem; 2021 Sep; 123(6):151774. PubMed ID: 34450502
[TBL] [Abstract][Full Text] [Related]
4. Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells.
Yoshida C; Niiya K; Niiya M; Shibakura M; Asaumi N; Tanimoto M
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):425-33. PubMed ID: 17581316
[TBL] [Abstract][Full Text] [Related]
5. Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Krstić J; Obradović H; Jauković A; Okić-Đorđević I; Trivanović D; Kukolj T; Mojsilović S; Ilić V; Santibañez JF; Bugarski D
Biochim Biophys Acta; 2015 Feb; 1853(2):431-44. PubMed ID: 25433194
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
7. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of urokinase-type plasminogen activator expression by basic fibroblast growth factor and serum in myogenesis. Requirement of a common mitogen-activated protein kinase pathway.
Miralles F; Ron D; Baiget M; Félez J; Muñoz-Cánoves P
J Biol Chem; 1998 Jan; 273(4):2052-8. PubMed ID: 9442043
[TBL] [Abstract][Full Text] [Related]
9. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
10. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.
Muñoz-Cánoves P; Miralles F; Baiget M; Félez J
Thromb Haemost; 1997 Mar; 77(3):526-34. PubMed ID: 9066006
[TBL] [Abstract][Full Text] [Related]
12. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
13. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
Montero L; Nagamine Y
Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311
[TBL] [Abstract][Full Text] [Related]
14. p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression.
Yu J; Bian D; Mahanivong C; Cheng RK; Zhou W; Huang S
J Biol Chem; 2004 Nov; 279(48):50446-54. PubMed ID: 15371454
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
Lee KH; Choi EY; Hyun MS; Eun JR; Jang BI; Kim TN; Lee HJ; Lee DS; Yun SS; Kim HJ; Kim JH; Kim JR
Tumori; 2008; 94(4):523-30. PubMed ID: 18822689
[TBL] [Abstract][Full Text] [Related]
17. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.
El Fahime E; Mills P; Lafreniere JF; Torrente Y; Tremblay JP
Exp Cell Res; 2002 Nov; 280(2):169-78. PubMed ID: 12413883
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia impairs cytotrophoblast function via stress signaling.
Cawyer CR; Horvat D; Leonard D; Allen SR; Jones RO; Zawieja DC; Kuehl TJ; Uddin MN
Am J Obstet Gynecol; 2014 Nov; 211(5):541.e1-8. PubMed ID: 24793974
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2.
Kocić J; Santibañez JF; Krstić A; Mojsilović S; Dorđević IO; Trivanović D; Ilić V; Bugarski D
Biochim Biophys Acta; 2012 Apr; 1823(4):838-49. PubMed ID: 22285818
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
